Study links limonene to CYP2C19 gene differences
Part of Genetic & congenital clinical trials.
This study looks at how a person’s CYP2C19 gene type affects how their body processes limonene (a citrus compound). The results may help researchers understand differences in drug and nutrient processing based on genetics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 44 years old (inclusive).
- Be of East Asian descent.
- You can be male or female.
- You must not be pregnant or breastfeeding.
- You must not have had serious allergy to limonene, citrus, bovine gelatin, or glycerin.
- You must not have a history of stroke or major heart blood-vessel problems, or chest pain/shortness of breath in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your environment (the air you breathe, things you touch, etc.) may affect your health. If you join, you'll help researchers understand these connections better.
This study checks how well your liver breaks down certain medications based on your genes. It aims to find new ways to predict your natural liver function, which could help doctors prescribe the right drug dose for you.
This study tests if a natural compound called d-limonene (found in citrus oils) can reduce anxiety that some people feel after using high-THC cannabis. You'll receive THC and d-limonene in capsules under medical supervision.
This study looks at how your genes affect the way your body handles medications. It aims to improve treatment by understanding genetic differences, especially if you take multiple medications.
This trial tests a dietary supplement called LIMICOL®-NG to see if it can lower LDL (bad) cholesterol in people with moderately high cholesterol. It may be an option if you are not already on cholesterol medication.
This study looks at how a specific gene (UGT2B17) affects how your body processes diclofenac, a common pain reliever. Healthy people aged 18 to 64 are needed to help understand genetic differences in drug metabolism.
Hear when a new CYP2C19 Genetic Variants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.